Treatment with rituximab, an approved CD20 inhibitor that’s sometimes used off-label for multiple sclerosis (MS), was found to adequately control the neurodegenerative disease in patients diagnosed during childhood or adolescence, a new study showed. The therapy, given by infusion into the bloodstream, was generally safe and significantly reduced…
symptoms
Surjeet Kaur’s MS journey involves sacrifice, but also awareness and positivity. (Photos courtesy of Surjeet Kaur) Day 14 of 31 This is Surjeet Kaur’s story: It was an ordinary day in November 2012 when I woke up with a stiff neck. I tried to brush this off thinking I…
At the age of 40, I’ve never passed my driving test. I know that’s shocking. Here in the United Kingdom, we must pass two sections to be licensed to drive: a theory test and the practical test. I’ve passed the theory part three times but was never able to pass…
Alex Ramirez stands outside of his home. (Photos courtesy of Alex Ramirez) Day 13 of 31 This is Alex Ramirez’s story: In January 2018, I started to feel terrible in a way I can’t put into words. I went to the hospital, and after multiple MRIs, I was prescribed…
In multiple sclerosis (MS), lesions in the brain may start with small clusters of immune cells called microglia, a new study reveals. Scientists are working to understand exactly how these small clusters may develop into MS lesions, which they hope could uncover new targets for treating the disease.
Faith Agauas takes a stroll by the waterfront. (Photos courtesy of Faith Agauas) Day 11 of 31 This is Faith Agauas’ story: My 70 years of life have been an amazing journey. I grew up in Detroit in a neighborhood filled with love and protection, music from Motown, and…
Tori Henderson receives her monthly infusion at an appointment. (Photos courtesy of Tori Henderson) Day 9 of 31 This is Tori Henderson’s story: Henderson, left, poses with her daughter, Kerriyah, for her birthday at Disney World. Thanksgiving 2017 will forever hold a special place in my memories. I…
The presence of paramagnetic rim lesions (PRLs), which represent areas of damage in the brain and spinal cord with chronic active inflammation, may help identify people with multiple sclerosis (MS) who are more likely to have cognitive decline over time. That’s according to four-year data presented by Hannah Schwartz,…
Sam Roman, MD, travels to Montana to conduct home visits for patients enrolled in the TREAT-MS clinical trial. (Photos courtesy of Sam Roman) Day 6 of 31 This is Sam Roman’s story: It was during a particularly stressful period of medical school in 2015 when I had my first…
Julie Stamm was diagnosed with multiple sclerosis in 2007. (Courtesy of Colorado Parent magazine) Day 5 of 31 This is Julie Stamm’s (@iamstamm) story: I was officially diagnosed with multiple sclerosis (MS) on Jan. 8, 2007. While I can date my symptoms back to six years before that,…
Bethany Carman runs her first 10K at the Mornington Running Festival in Australia. (Photos courtesy of Bethany Carman) Day 4 of 31 This is Bethany Carman’s story: Hello, I’m Beth. I’m 30 years old, based in Melbourne, Australia, and I was diagnosed with relapsing-remitting multiple sclerosis (MS)…
There are several good reasons why you won’t see me in television commercials for multiple sclerosis (MS) treatments anytime soon. For one, I’m not much of an actor, despite my brief moment of high school fame. For another, even though I wouldn’t go so far as to say that…
Two researchers from The University of Western Australia (UWA) have received grants from MS Australia for work that may help scientists better understand how an immune system gone awry can cause multiple sclerosis (MS). Belinda Kaskow, PhD, a teaching and research fellow at UWA’s School of Biomedical Sciences,…
We’ve all heard comments from people who aren’t educated about multiple sclerosis (MS). Some that I’ve heard include “My friend had that and is fine now,” “Eating better will fix you,” and “Try a parasite cleanse.” I have to chuckle at these statements. With March not far away,…
An association between the proteins IgG1 and CXCL10 in the fluid around the brain may help predict the risk of future disease activity for people in the early stages of multiple sclerosis (MS). That’s according to “CXCL10/IgG1 Axis in Multiple Sclerosis as a Potential Predictive Biomarker…
Black people with multiple sclerosis (MS) scored lower on tests of walking and physical function than did white patients, regardless of social determinants of health such as education or income, a U.S. study reported. These findings add to a growing understanding of how MS manifests in Black people, and…
An imaging feature called the T1-dark rim, which is visible on standard MRI scans of people with multiple sclerosis (MS), could help to identify paramagnetic rim lesions (PRLs), a study suggests. PRLs are regions of chronic active inflammation that cause ongoing nerve damage. They’re associated with disease activity and…
Sweden has a consistently high incidence and prevalence of pediatric-onset multiple sclerosis (PoMS), according to a recently published study. Incidence measures the number of new cases identified during a certain period, while prevalence measures the proportion of people in the population with the condition. Data show the disease is…
Complement proteins, especially when activated in the brain and spinal cord, may contribute to nerve cell damage and more severe multiple sclerosis (MS) symptoms, a study that offers insights into a possible therapeutic target suggests. The study, “Complement Activation Is Associated With Disease Severity in Multiple Sclerosis,” was…
The presence in the brain of chronic inflammatory lesions — called paramagnetic rim lesions (PRLs) — in people with multiple sclerosis (MS) is associated with a greater relapse burden and faster disability progression in the long term, according to a new U.S. study. Among more than 150 patients who…
Nabiximols, a cannabis-based oral spray sold as Sativex, was reported to considerably ease spasticity — unusual muscle tightness or stiffness — in about two-thirds of the multiple sclerosis (MS) patients using it for three months in a real-world study in Germany. For most patients, the treatment also…
A small clinical trial in Texas is testing whether a noninvasive magnetic brain stimulation procedure can ease the symptoms of overactive bladder in adults with multiple sclerosis (MS). The randomized Phase 2 study (NCT06072703) is ongoing at Houston Methodist Hospital, and is recruiting about 29 women with stable…
As those of us with multiple sclerosis (MS) know, every so often a call comes or a letter arrives telling us we have a date with an extraordinary friend: the magnetic resonance imaging (MRI) scanner. For me, it seems that time has arrived again. Just a few days…
Measuring levels of nitric oxide metabolites in the blood could be a diagnostic biomarker for multiple sclerosis (MS), recent research suggests. The molecules, collectively called NOx, were elevated in the blood of people with relapsing-remitting MS (RRMS) and primary-progressive MS…
In neurological inflammatory conditions like multiple sclerosis (MS), inflammatory immune cells may enter the brain through arachnoid cuff exit (ACE) points — newly discovered structures that normally seem to serve as a type of sewer system in the brain, helping to move out waste. Figuring out exactly how immune…
Some people with secondary progressive multiple sclerosis (SPMS) using Mayzent (siponimod) show a severe drop in their number of lymphocytes, a condition known as lymphopenia, shortly after starting treatment, a report on its real-world use in the U.K. found. Lymphocytes are white blood cells that help the immune…
A non-invasive scan that measures network activity across the brain was able to predict the outcomes of behavioral therapies designed to improve cognitive function in people with multiple sclerosis (MS), a study demonstrates. Brain network function, as assessed by the test, called magnetoencephalography (MEG), “could play an important role…
Pelvic floor exercises, which strengthen the muscles around the bladder, bowel, and vagina, can help with sexual health and lessen sex-related distress in women with multiple sclerosis (MS), a small study found. Women reported increased sexual desire, arousal, and better overall satisfaction after engaging in a 12-week training program,…
Scientists have developed a technique to more precisely map the myelin sheath, the fatty covering around nerve fibers that is damaged in multiple sclerosis (MS), in people undergoing an imaging scan. While further work is needed, its use “produced promising initial results,” the scientists wrote, noting that this…
Fatigue is a significant predictor of worse health-related quality of life in adults with relapsing-remitting multiple sclerosis (RRMS), a study reports. High levels of fatigue were significantly linked with worse physical and mental health, including cognitive impairments, depression, and anxiety. The findings suggest…